HUMANA INC (HUM)

US4448591028 - Common Stock

320.54  -0.44 (-0.14%)

After market: 320.54 0 (0%)

Fundamental Rating

4

Overall HUM gets a fundamental rating of 4 out of 10. We evaluated HUM against 118 industry peers in the Health Care Providers & Services industry. There are concerns on the financial health of HUM while its profitability can be described as average. HUM has a decent growth rate and is not valued too expensively. Finally HUM also has an excellent dividend rating.



5

1. Profitability

1.1 Basic Checks

HUM had positive earnings in the past year.
HUM had a negative operating cash flow in the past year.
HUM had positive earnings in each of the past 5 years.
In the past 5 years HUM always reported a positive cash flow from operatings.

1.2 Ratios

The Return On Assets of HUM (3.97%) is better than 75.86% of its industry peers.
HUM has a Return On Equity of 12.34%. This is amongst the best in the industry. HUM outperforms 80.17% of its industry peers.
The Return On Invested Capital of HUM (7.40%) is better than 77.59% of its industry peers.
HUM had an Average Return On Invested Capital over the past 3 years of 8.25%. This is in line with the industry average of 8.58%.
Industry RankSector Rank
ROA 3.97%
ROE 12.34%
ROIC 7.4%
ROA(3y)6.14%
ROA(5y)7.47%
ROE(3y)17.29%
ROE(5y)19.78%
ROIC(3y)8.25%
ROIC(5y)9.55%

1.3 Margins

Looking at the Profit Margin, with a value of 1.82%, HUM is in the better half of the industry, outperforming 67.24% of the companies in the same industry.
HUM's Profit Margin has declined in the last couple of years.
HUM has a Operating Margin (3.76%) which is comparable to the rest of the industry.
HUM's Operating Margin has declined in the last couple of years.
Industry RankSector Rank
OM 3.76%
PM (TTM) 1.82%
GM N/A
OM growth 3Y-12.77%
OM growth 5Y-4.67%
PM growth 3Y-18.76%
PM growth 5Y-4.58%
GM growth 3YN/A
GM growth 5YN/A

2

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so HUM is still creating some value.
HUM has less shares outstanding than it did 1 year ago.
HUM has less shares outstanding than it did 5 years ago.
Compared to 1 year ago, HUM has an improved debt to assets ratio.

2.2 Solvency

HUM has a Debt/Equity ratio of 0.78. This is a neutral value indicating HUM is somewhat dependend on debt financing.
HUM has a Debt to Equity ratio (0.78) which is comparable to the rest of the industry.
Industry RankSector Rank
Debt/Equity 0.78
Debt/FCF N/A
Altman-Z N/A
ROIC/WACC0.96
WACC7.7%

2.3 Liquidity

Industry RankSector Rank
Current Ratio N/A
Quick Ratio N/A

6

3. Growth

3.1 Past

HUM shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -10.21%.
The Earnings Per Share has been growing by 12.30% on average over the past years. This is quite good.
HUM shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 14.22%.
HUM shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 13.33% yearly.
EPS 1Y (TTM)-10.21%
EPS 3Y11.52%
EPS 5Y12.3%
EPS growth Q2Q-22.92%
Revenue 1Y (TTM)14.22%
Revenue growth 3Y11.3%
Revenue growth 5Y13.33%
Revenue growth Q2Q10.73%

3.2 Future

The Earnings Per Share is expected to grow by 15.12% on average over the next years. This is quite good.
HUM is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 8.34% yearly.
EPS Next Y-36.42%
EPS Next 2Y-4.71%
EPS Next 3Y4.92%
EPS Next 5Y15.12%
Revenue Next Year8.06%
Revenue Next 2Y5.84%
Revenue Next 3Y5.52%
Revenue Next 5Y8.34%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.

4

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 13.45, HUM is valued correctly.
Based on the Price/Earnings ratio, HUM is valued cheaper than 91.38% of the companies in the same industry.
When comparing the Price/Earnings ratio of HUM to the average of the S&P500 Index (28.28), we can say HUM is valued rather cheaply.
Based on the Price/Forward Earnings ratio of 13.58, the valuation of HUM can be described as correct.
Based on the Price/Forward Earnings ratio, HUM is valued cheaply inside the industry as 82.76% of the companies are valued more expensively.
HUM is valuated rather cheaply when we compare the Price/Forward Earnings ratio to 20.88, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 13.45
Fwd PE 13.58

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, HUM is valued cheaper than 82.76% of the companies in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 9.06

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)1.09
EPS Next 2Y-4.71%
EPS Next 3Y4.92%

7

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 1.10%, HUM has a reasonable but not impressive dividend return.
Compared to an average industry Dividend Yield of 2.73, HUM pays a better dividend. On top of this HUM pays more dividend than 84.48% of the companies listed in the same industry.
With a Dividend Yield of 1.10, HUM pays less dividend than the S&P500 average, which is at 2.41.
Industry RankSector Rank
Dividend Yield 1.1%

5.2 History

The dividend of HUM is nicely growing with an annual growth rate of 12.51%!
HUM has paid a dividend for at least 10 years, which is a reliable track record.
HUM has not decreased its dividend in the past 5 years, so it has a somewhat stable track record.
Dividend Growth(5Y)12.51%
Div Incr Years7
Div Non Decr Years7

5.3 Sustainability

HUM pays out 22.10% of its income as dividend. This is a sustainable payout ratio.
The dividend of HUM is growing, but earnings are growing more, so the dividend growth is sustainable.
DP22.1%
EPS Next 2Y-4.71%
EPS Next 3Y4.92%

HUMANA INC

NYSE:HUM (5/3/2024, 7:04:00 PM)

After market: 320.54 0 (0%)

320.54

-0.44 (-0.14%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap38.63B
Analysts
Price Target
Dividend
Industry RankSector Rank
Dividend Yield 1.1%
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
Industry RankSector Rank
PE 13.45
Fwd PE 13.58
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)1.09
Profitability
Industry RankSector Rank
ROA 3.97%
ROE 12.34%
ROCE
ROIC
ROICexc
ROICexgc
OM 3.76%
PM (TTM) 1.82%
GM N/A
FCFM
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover2.18
Health
Industry RankSector Rank
Debt/Equity 0.78
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio N/A
Quick Ratio N/A
Altman-Z
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
Growth
EPS 1Y (TTM)-10.21%
EPS 3Y11.52%
EPS 5Y
EPS growth Q2Q
EPS Next Y-36.42%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)14.22%
Revenue growth 3Y11.3%
Revenue growth 5Y
Revenue growth Q2Q
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y